These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8794015)

  • 21. On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(-)/-) mutant mice.
    Karrer U; Althage A; Odermatt B; Roberts CW; Korsmeyer SJ; Miyawaki S; Hengartner H; Zinkernagel RM
    J Exp Med; 1997 Jun; 185(12):2157-70. PubMed ID: 9182687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
    Kafrouni MI; Brown GR; Thiele DL
    J Immunol; 2001 Aug; 167(3):1566-74. PubMed ID: 11466378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins.
    Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alpha interferon, antiviral proteins and their value in clinical medicine].
    Chieux V; Hober D; Chehadeh W; Wattré P
    Ann Biol Clin (Paris); 1999; 57(6):659-66. PubMed ID: 10572214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity.
    Kägi D; Odermatt B; Ohashi PS; Zinkernagel RM; Hengartner H
    J Exp Med; 1996 May; 183(5):2143-52. PubMed ID: 8642324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected].
    Planz O; Seiler P; Hengartner H; Zinkernagel RM
    Nature; 1996 Aug; 382(6593):726-9. PubMed ID: 8751445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of viral life-cycle in response to cytotoxic T lymphocyte-mediated immunity.
    Louzoun Y; Ganusov VV
    J Theor Biol; 2012 Oct; 310():3-13. PubMed ID: 22735670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8+ T-cell memory to viruses.
    Doherty PC; Hou S; Tripp RA
    Curr Opin Immunol; 1994 Aug; 6(4):545-52. PubMed ID: 7946041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies and B cell memory in viral immunity.
    Dörner T; Radbruch A
    Immunity; 2007 Sep; 27(3):384-92. PubMed ID: 17892847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population dynamics of immune responses to persistent viruses.
    Nowak MA; Bangham CR
    Science; 1996 Apr; 272(5258):74-9. PubMed ID: 8600540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential contribution of Fas- and perforin-mediated mechanisms to the cell-mediated cytotoxic activity of naive and in vivo-primed intestinal intraepithelial lymphocytes.
    Corazza N; Müller S; Brunner T; Kägi D; Mueller C
    J Immunol; 2000 Jan; 164(1):398-403. PubMed ID: 10605035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    Selin LK; Nahill SR; Welsh RM
    J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic T cell responses.
    Ludewig B; Jäggi M; Dumrese T; Brduscha-Riem K; Odermatt B; Hengartner H; Zinkernagel RM
    J Immunol; 2001 Mar; 166(5):3369-76. PubMed ID: 11207293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunology of viral infections.
    Oh JO
    Int Ophthalmol Clin; 1985; 25(2):107-16. PubMed ID: 3874186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection and damage by antiviral immunity.
    Zinkernagel RM
    Harvey Lect; 1993-1994; 89():29-51. PubMed ID: 7622361
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunological control of murine gammaherpesvirus infection is independent of perforin.
    Usherwood EJ; Brooks JW; Sarawar SR; Cardin RD; Young WD; Allen DJ; Doherty PC; Nash AA
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():2025-30. PubMed ID: 9267003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional role of type I and type II interferons in antiviral defense.
    Müller U; Steinhoff U; Reis LF; Hemmi S; Pavlovic J; Zinkernagel RM; Aguet M
    Science; 1994 Jun; 264(5167):1918-21. PubMed ID: 8009221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral strategies of immune evasion.
    Ploegh HL
    Science; 1998 Apr; 280(5361):248-53. PubMed ID: 9535648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral protein production in homogeneous and mixed infections of cytopathic and noncytopathic BVD virus.
    Ridpath JF; Bolin SR
    Arch Virol; 1990; 111(3-4):247-56. PubMed ID: 2162163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.